Zusammenfassung
Häufigkeit: Nur 4% der Malignome im Rektum-Anus-Bereich betreffen Tumoren der Analregion, entsprechend nur 1% sämtlicher Malignome im gastrointestinalen Bereich.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Allal A, Kurtz JM, Pipard G et al. (1993) Chemoradiotherapy versus radiotherapy alone for anal cancer: A retrospective comparison. Int J Radiat Oncol Biol Phys 27: 59–66
Brunet R, Sadekh S, Vignoud Jet al. (1990) Cisplatin (P) and 5-fluorouracil (5-FU) for the neoadjuvant treatment (Tt) of epidermoid anal canal carcinoma ( EACC ). Proc Am Soc Clin Oncol 9: 104
Cummings BJ, Keane TJ, O’Sullivan B, Wong CS, Catton CN (1991) Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiol Oncol Biol Phys 21: 115
Flam MS, John M, Pajak T, Petrelli N, Myerson R, Doget S (1995) Radiation (RT) and 5-fluorouracil (5-FU) versus radiation, 5-FU, mitomycin C ( MMC) in the treatment of anal carcinoma: Results of a phase-III RTOG/ECOG Intergroup Trial. Proc Am Soc Clin Oncol 14: 443
Mahjoubi M, Sadek H, Francois E et al. (1990) Epidermoid anal canal carcinoma (EACC): Activity of cisplaltin (P) and continuous 5-fluorouracil (5-FU) in metastatic (M) and/or local recurrent ( LR) diesease. Proc Am Soc Clin Oncol 9: 114
Panzer M, Sutter T, Wendt T, Jauch K-W (1993) Radiochemotherapie mit und ohne Radikaloperation bei Analkarzinom: Großhadener Langzeitergebnisse. Tumordiagn Ther 14: 167–174
Roelofsen R, Bosset JF, Esschwege F, Wann-Glamecke M von, Barteling H et al. (1995) Concomittant radiotherapy and chemotherapy superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase-III randomized trial of the EORTC Radiotherapy and Gastrointestinal Cooperative Groups Proc Am Soc Clin Oncol 14
Schlag P (1989) Chirurgische und multimodale Therapie des Anal-Karzinoms. In: Schmoll H-J, Meyer H-J. Wilke H, Pichlmayr R (Hrsg) Aktuelle Therapie gastrointestinaler Tumoren. Springer, Berlin Heidelberg New York Tokyo, S 385–395
Scholefield JH, Sonnex C, Talbot IC et al. (1989) Anal and cervical intraepithelial neoplasia: possible parallel. Lancet 2: 765
Tanum G, Tveit KM, Karlsen KO (1993) Chemoradiotherapy of anal carcinoma: Tumor response and acute toxicity. Oncology 50: 14–17
Touboul E, Schlienger M, Buffat L et al. (1994) Epidermoid carcinoma of the anal canal. Cancer 73 (6): 1569–1579
Witzigmann H, Hehl AJ, Meyer M, Witte J (1994) Treatment of anal cancer. Onkologie 17: 398–401
You YT, Wang JY, Changchien CR et al. (1993) An alternative treatment of anal squamous cell carcinoma: Combined radiotherapy and chemotherapy. J Surg Oncol 52: 42–45
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schmoll, H.J., Dunst, J., Schlag, P.M. (1997). Analkarzinom. In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12175-7_36
Download citation
DOI: https://doi.org/10.1007/978-3-662-12175-7_36
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-60830-1
Online ISBN: 978-3-662-12175-7
eBook Packages: Springer Book Archive